Publications by authors named "Deborah A Knight"

Claim this Profile
H
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Deborah A Knight, Shin Foong Ngiow, Ming Li, Tiffany Parmenter, Stephen Mok

J Clin Invest· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer.
Stephin J Vervoort, Sarah A Welsh, Jennifer R Devlin, Elisa Barbieri, Deborah A Knight

Cell· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Analysis of Brd4 Displacement in the Control of B Cell Survival, Proliferation, and Differentiation.
Isabella Y Kong, Joel S Rimes, Amanda Light, Izabela Todorovski, Sarah Jones, Deborah A Knight

Cell Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK13 cooperates with CDK12 to control global RNA polymerase II processivity.
Zheng Fan, Jennifer R Devlin, Simon J Hogg, Maria A Doyle, Paul F Harrison, Deborah A Knight

Sci Adv· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias.
Sang-Kyu Kim, Deborah A Knight, Lisa R Jones, Stephin Vervoort, Ashley P Ng

Genes Dev· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor immune evasion arises through loss of TNF sensitivity.
Conor J Kearney, Stephin J Vervoort, Simon J Hogg, Kelly M Ramsbottom, Andrew J Freeman, Deborah A Knight

Sci Immunol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake of bright fluorophore core-silica shell nanoparticles by biological systems.
Andrew Zane, Christie McCracken, Deborah A Knight, Tanya Young, Anthony D Lutton

Int J Nanomedicine· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Deborah A Knight, Shin Foong Ngiow, Ming Li, Tiffany Parmenter, Stephen Mok

J Clin Invest· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative stress-mediated inhibition of intestinal epithelial cell proliferation by silver nanoparticles.
Christie McCracken, Andrew Zane, Deborah A Knight, Elizabeth Hommel, Prabir K Dutta

Toxicol In Vitro· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Batf3-independent langerin- CX3CR1- CD8α+ splenic DCs represent a precursor for classical cross-presenting CD8α+ DCs.
Troels R Petersen, Deborah A Knight, Ching-Wen Tang, Taryn L Osmond, Ian F Hermans

J Leukoc Biol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy.
Regan J Anderson, Ching-wen Tang, Naomi J Daniels, Benjamin J Compton, Colin M Hayman, Deborah A Knight

Nat Chem Biol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors.
Michaela Waibel, Vanessa S Solomon, Deborah A Knight, Rachael A Ralli, Sang-Kyu Kim

Cell Rep· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal intestinal epithelial cell toxicity in response to short- and long-term food-relevant inorganic nanoparticle exposure.
Christie McCracken, Andrew Zane, Deborah A Knight, Prabir K Dutta, W James Waldman

Chem Res Toxicol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events.
Philip F Binkley, Glen E Cooke, Amanda Lesinski, Mackenzie Taylor, Min Chen, Deborah A Knight

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for CCL2 in both tumor progression and immunosurveillance.
Ming Li, Deborah A Knight, Linda A Snyder, Mark J Smyth, Trina J Stewart

Oncoimmunology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF-targeted therapy and immune responses to melanoma.
Shin Foong Ngiow, Deborah A Knight, Antoni Ribas, Grant A McArthur, Mark J Smyth

Oncoimmunology· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Deborah A Knight, Shin Foong Ngiow, Ming Li, Tiffany Parmenter, Stephen Mok

J Clin Invest· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immature murine NKT cells pass through a stage of developmentally programmed innate IL-4 secretion.
Nina Dickgreber, Kathryn J Farrand, Nicholas van Panhuys, Deborah A Knight, Sara J McKee

J Leukoc Biol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways.
Ming Li, Deborah A Knight, Mark J Smyth, Trina J Stewart

Cancer Immunol Immunother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species-specific activity of glycolipid ligands for invariant NKT cells.
Emma M Dangerfield, Janice M H Cheng, Deborah A Knight, Robert Weinkove, P Rod Dunbar

Chembiochem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
Melinda C Cox Dunn, Deborah A Knight, W James Waldman

Antivir Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved synthesis of dansylated α-galactosylceramide and its use as a fluorescent probe for the monitoring of glycolipid uptake by cells.
Janice M H Cheng, Stephanie H Chee, Deborah A Knight, Hans Acha-Orbea, Ian F Hermans

Carbohydr Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
Troels R Petersen, Dianne Sika-Paotonu, Deborah A Knight, Helen M A Simkins, Ian F Hermans

PLoS One· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Rebecca C Girvan, Deborah A Knight, Chris J O'Loughlin, Colin M Hayman, Ian F Hermans

Vaccine· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.
Troels R Petersen, Dianne Sika-Paotonu, Deborah A Knight, Nina Dickgreber, Kathryn J Farrand

Immunol Cell Biol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis